| HGNC Family | Tumor necrosis factor (ligand) superfamily (TNFSF) |
| Name | tumor necrosis factor (ligand) superfamily, member 9 |
| Description | The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This transmembrane cytokine is a bidirectional signal transducer that acts as a ligand for TNFRSF9/4-1BB, which is a costimulatory receptor molecule in T lymphocytes. This cytokine and its receptor are involved in the antigen presentation process and in the generation of cytotoxic T cells. The receptor TNFRSF9/4-1BB is absent from resting T lymphocytes but rapidly expressed upon antigenic stimulation. The ligand encoded by this gene, TNFSF9/4-1BBL, has been shown to reactivate anergic T lymphocytes in addition to promoting T lymphocyte proliferation. This cytokine has also been shown to be required for the optimal CD8 responses in CD8 T cells. This cytokine is expressed in carcinoma cell lines, and is thought to be involved in T cell-tumor cell interaction.[provided by RefSeq, Oct 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTNFSF9, also known as 4–1BB ligand (4–1BBL) or CD137L, is a potent costimulatory molecule predominantly expressed by activated antigen‐presenting cells including dendritic cells, monocytes, and certain B‐cell subsets, as well as by some tumor cells. Engagement of TNFSF9 with its receptor 4–1BB (CD137) on activated T cells supports cellular activation, expansion, and survival; it enhances cytokine production (such as IL–2 and IFN–γ) and cytolytic effector function while also contributing to the reversal of T cell anergy. In addition, TNFSF9 contributes to both direct (autocostimulation) and indirect (transcostimulation) signaling across the immunological synapse, thereby amplifying T-cell responses and shaping adaptive immunity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its classical role in T-cell costimulation, TNFSF9 also transduces “reverse signals” into the cells that express it. Such reverse signaling can promote dendritic cell maturation, influence the production of inflammatory mediators (including TNF, IL–12, and IL–10), and affect the migration and polarization of macrophages, thereby contributing to sustained cytokine production and fine-tuning of immune responses. Moreover, these signaling events involve activation of downstream pathways—such as MAP kinases (e.g., p38, ERK), NF–κB, CREB, and others—that help regulate not only the timing of early versus late cytokine production following Toll-like receptor engagement but also modulate inflammatory responses in diverse contexts including sepsis, atherosclerosis, and certain malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe unique bidirectional properties of TNFSF9 have been exploited in clinical and therapeutic contexts. Strategies that engage TNFSF9—either through agonistic antibodies or through engineered fusion proteins integrating costimulatory domains—have demonstrated the ability to enhance ex vivo expansion of NK cells and CD8+ T cells, reverse T cell anergy, and potentiate antigen-specific anticancer responses. In various tumor models, including pancreatic, colorectal, and T-cell lymphomas, targeting the TNFSF9/4–1BB pathway has proven beneficial in reshaping the tumor microenvironment, overcoming immune evasion, and improving therapeutic outcomes by promoting robust T-cell and natural killer cell activity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "36", "end_ref": "41"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Tao Wen, Jacob Bukczynski, Tania H Watts "}, {"type": "b", "children": [{"type": "t", "text": "4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.168.10.4897"}], "href": "https://doi.org/10.4049/jimmunol.168.10.4897"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11994439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11994439"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Young-June Kim, Geling Li, Hal E Broxmeyer "}, {"type": "b", "children": [{"type": "t", "text": "4-1BB ligand stimulation enhances myeloid dendritic cell maturation from human umbilical cord blood CD34+ progenitor cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hematother Stem Cell Res (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/152581602321080556"}], "href": "https://doi.org/10.1089/152581602321080556"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12590704"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12590704"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jacob Bukczynski, Tao Wen, Tania H Watts "}, {"type": "b", "children": [{"type": "t", "text": "Costimulation of human CD28- T cells by 4-1BB ligand."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/immu.200310020"}], "href": "https://doi.org/10.1002/immu.200310020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12645943"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12645943"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Camilla Reali, Monica Curto, Valeria Sogos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: modulation by FGF-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci Res (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jnr.10727"}], "href": "https://doi.org/10.1002/jnr.10727"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "13130507"}], "href": "https://pubmed.ncbi.nlm.nih.gov/13130507"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Diego Laderach, Amy Wesa, Anne Galy "}, {"type": "b", "children": [{"type": "t", "text": "4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Immunol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellimm.2003.11.003"}], "href": "https://doi.org/10.1016/j.cellimm.2003.11.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14746806"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14746806"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yoshinori Seko, Kazuyuki Sugishita, Osamu Sato, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of costimulatory molecules (4-1BBL and Fas) and major histocompatibility class I chain-related A (MICA) in aortic tissue with Takayasu's arteritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Vasc Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000076437"}], "href": "https://doi.org/10.1159/000076437"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14752253"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14752253"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Hyo Won Jung, Seung Won Choi, Jung I L Choi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Mol Med (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/emm.2004.2"}], "href": "https://doi.org/10.1038/emm.2004.2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15031666"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15031666"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Catherine Rabu, Agnès Quéméner, Yannick Jacques, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M506881200"}], "href": "https://doi.org/10.1074/jbc.M506881200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16204238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16204238"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Sara Ek, Erik Björck, Carl-Magnus Högerkorp, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4-1BB-L implicated in cell survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.21579"}], "href": "https://doi.org/10.1002/ijc.21579"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16287062"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16287062"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Young Jun Kang, Sung Ouk Kim, Shigeki Shimada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Immunol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ni1471"}], "href": "https://doi.org/10.1038/ni1471"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17496895"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17496895"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Mojtaba Habib-Agahi, Thanh T Phan, Peter F Searle "}, {"type": "b", "children": [{"type": "t", "text": "Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Immunol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/intimm/dxm106"}], "href": "https://doi.org/10.1093/intimm/dxm106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17977894"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17977894"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Matthias T Stephan, Vladimir Ponomarev, Renier J Brentjens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm1676"}], "href": "https://doi.org/10.1038/nm1676"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18026115"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18026115"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Undine Lippert, Karolin Zachmann, David M Ferrari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/eji.200737800"}], "href": "https://doi.org/10.1002/eji.200737800"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18395851"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18395851"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Petra Krause, Markus Bruckner, Christina Uermösi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2008-05-157123"}], "href": "https://doi.org/10.1182/blood-2008-05-157123"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19029446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19029446"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Mojtaba Habib-Agahi, Mansooreh Jaberipour, Peter F Searle "}, {"type": "b", "children": [{"type": "t", "text": "4-1BBL costimulation retrieves CD28 expression in activated T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Immunol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellimm.2009.01.003"}], "href": "https://doi.org/10.1016/j.cellimm.2009.01.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19217084"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19217084"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Songwen Ju, Songguang Ju, Yan Ge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Immunol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/intimm/dxp077"}], "href": "https://doi.org/10.1093/intimm/dxp077"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19684160"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19684160"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Bérengère Vire, Stéphane de Walque, Audrey Restouin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0007085"}], "href": "https://doi.org/10.1371/journal.pone.0007085"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19759901"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19759901"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Tina Baessler, Jean Enno Charton, Benjamin Joachim Schmiedel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2009-06-227934"}], "href": "https://doi.org/10.1182/blood-2009-06-227934"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20008791"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20008791"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Eun-Young Won, Kiweon Cha, Jung-Sue Byun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The structure of the trimer of human 4-1BB ligand is unique among members of the tumor necrosis factor superfamily."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.084442"}], "href": "https://doi.org/10.1074/jbc.M109.084442"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20032458"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20032458"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Charles Gullo, Liang Kai Koh, Wan Lu Pang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0010845"}], "href": "https://doi.org/10.1371/journal.pone.0010845"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20520765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20520765"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "W Gong, W Xiao, M Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tissue Antigens (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1399-0039.2010.01535.x"}], "href": "https://doi.org/10.1111/j.1399-0039.2010.01535.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20670353"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20670353"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Chenxuan Wu, Hongxing Guo, Yijun Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Extracellular domain of human 4-1BBL enhanced the function of cytotoxic T-lymphocyte induced by dendritic cell."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Immunol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellimm.2011.06.013"}], "href": "https://doi.org/10.1016/j.cellimm.2011.06.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21745658"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21745658"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Alexander C Dowell, Kimberley A Oldham, Rupesh I Bhatt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Immunol Immunother (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00262-011-1122-3"}], "href": "https://doi.org/10.1007/s00262-011-1122-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22021067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22021067"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Daniela Bellarosa, Alessandro Bressan, Mario Bigioni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SAHA/Vorinostat induces the expression of the CD137 receptor/ligand system and enhances apoptosis mediated by soluble CD137 receptor in a human breast cancer cell line."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2012.1551"}], "href": "https://doi.org/10.3892/ijo.2012.1551"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22797667"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22797667"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Shuchun Zhao, Haiyu Zhang, Ying Xing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 ligand is expressed in primary and secondary lymphoid follicles and in B-cell lymphomas: diagnostic and therapeutic implications."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Surg Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAS.0b013e318268c6ea"}], "href": "https://doi.org/10.1097/PAS.0b013e318268c6ea"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23095505"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23095505"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Mei Chung Moh, Paolo Alberto Lorenzini, Charles Gullo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor necrosis factor receptor 1 associates with CD137 ligand and mediates its reverse signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.12-225250"}], "href": "https://doi.org/10.1096/fj.12-225250"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23620528"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23620528"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Jianhui Ma, Bo-Ram Bang, Jiawei Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The TNF family member 4-1BBL sustains inflammation by interacting with TLR signaling components during late-phase activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Signal (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scisignal.2004431"}], "href": "https://doi.org/10.1126/scisignal.2004431"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24084649"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24084649"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Vanessa Kermer, Nora Hornig, Markus Harder, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combining antibody-directed presentation of IL-15 and 4-1BBL in a trifunctional fusion protein for cancer immunotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-13-0282"}], "href": "https://doi.org/10.1158/1535-7163.MCT-13-0282"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24198185"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24198185"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Yingying Qian, Dong Pei, Ting Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-015-0499-9"}], "href": "https://doi.org/10.1007/s12032-015-0499-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25631633"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25631633"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Chunhui Jin, Yingying Liu, Jianhong Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Recombinant Salmonella-based CEACAM6 and 4-1BBL vaccine enhances T-cell immunity and inhibits the development of colorectal cancer in rats: In vivo effects of vaccine containing 4-1BBL and CEACAM6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2015.3901"}], "href": "https://doi.org/10.3892/or.2015.3901"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25872647"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25872647"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Zulkarnain Harfuddin, Bhushan Dharmadhikari, Siew Cheng Wong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional and functional characterization of CD137L-dendritic cells identifies a novel dendritic cell phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep29712"}], "href": "https://doi.org/10.1038/srep29712"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27431276"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27431276"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Yu Ling Shen, Yu Gan, Hai Feng Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Dig Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1751-2980.12489"}], "href": "https://doi.org/10.1111/1751-2980.12489"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28547807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28547807"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Aruna Bitra, Tzanko Doukov, Michael Croft, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA118.003176"}], "href": "https://doi.org/10.1074/jbc.RA118.003176"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29720398"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29720398"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Hiroaki Kamijo, Tomomitsu Miyagaki, Naomi Shishido-Takahashi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2018-04-845834"}], "href": "https://doi.org/10.1182/blood-2018-04-845834"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30194255"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30194255"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Aruna Bitra, Tzanko Doukov, Giuseppe Destito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crystal structure of the m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon 4-1BB receptor binding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA118.006297"}], "href": "https://doi.org/10.1074/jbc.RA118.006297"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30545939"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30545939"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Qun Zeng, Yubin Zhou, Herbert Schwarz "}, {"type": "b", "children": [{"type": "t", "text": "CD137L-DCs, Potent Immune-Stimulators-History, Characteristics, and Perspectives."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2019.02216"}], "href": "https://doi.org/10.3389/fimmu.2019.02216"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31632390"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31632390"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Jiao Wu, Yunpeng Wang, Zheng Jiang "}, {"type": "b", "children": [{"type": "t", "text": "TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gastrointest Cancer (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12029-020-00371-6"}], "href": "https://doi.org/10.1007/s12029-020-00371-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32077004"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32077004"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "David Y Fann, Emily Pauline Nickles, Luting Poh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD137 Ligand-CD137 Interaction is Required For Inflammasome-Associated Brain Injury Following Ischemic Stroke."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromolecular Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12017-020-08623-1"}], "href": "https://doi.org/10.1007/s12017-020-08623-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33073305"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33073305"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Alejandra G Martinez-Perez, Jose J Perez-Trujillo, Rodolfo Garza-Morales, et al. "}, {"type": "b", "children": [{"type": "t", "text": "4-1BBL as a Mediator of Cross-Talk between Innate, Adaptive, and Regulatory Immunity against Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms22126210"}], "href": "https://doi.org/10.3390/ijms22126210"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34207500"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34207500"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Jiao Wu, Yunpeng Wang, Yichun Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TNFSF9 promotes metastasis of pancreatic cancer through Wnt/Snail signaling and M2 polarization of macrophages."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.203497"}], "href": "https://doi.org/10.18632/aging.203497"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34517345"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34517345"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Jiao Wu, Yunpeng Wang "}, {"type": "b", "children": [{"type": "t", "text": "Role of TNFSF9 bidirectional signal transduction in antitumor immunotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Pharmacol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejphar.2022.175097"}], "href": "https://doi.org/10.1016/j.ejphar.2022.175097"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35714694"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35714694"}]}]}]}
|
| Synonyms | CD137L, TNLG5A, 4-1BB-L |
| Proteins | TNFL9_HUMAN |
| NCBI Gene ID | 8744 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TNFSF9 has 8,338 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 112 datasets.
Click the + buttons to view associations for TNFSF9 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TNFSF9 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TNFSF9 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TNFSF9 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of TNFSF9 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TNFSF9 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving TNFSF9 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFSF9 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TNFSF9 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TNFSF9 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of TNFSF9 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TNFSF9 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFSF9 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with TNFSF9 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TNFSF9 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TNFSF9 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TNFSF9 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of TNFSF9 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TNFSF9 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TNFSF9 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TNFSF9 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TNFSF9 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TNFSF9 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TNFSF9 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with TNFSF9 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with TNFSF9 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with TNFSF9 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of TNFSF9 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TNFSF9 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with TNFSF9 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TNFSF9 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TNFSF9 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with TNFSF9 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TNFSF9 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TNFSF9 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TNFSF9 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TNFSF9 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with TNFSF9 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with TNFSF9 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFSF9 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with TNFSF9 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TNFSF9 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TNFSF9 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TNFSF9 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TNFSF9 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TNFSF9 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TNFSF9 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TNFSF9 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving TNFSF9 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving TNFSF9 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving TNFSF9 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TNFSF9 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by TNFSF9 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by TNFSF9 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by TNFSF9 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of TNFSF9 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TNFSF9 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TNFSF9 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TNFSF9 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with TNFSF9 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFSF9 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFSF9 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of TNFSF9 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of TNFSF9 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TNFSF9 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for TNFSF9 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with TNFSF9 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for TNFSF9 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TNFSF9 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TNFSF9 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TNFSF9 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving TNFSF9 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving TNFSF9 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TNFSF9 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFSF9 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with TNFSF9 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TNFSF9 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of TNFSF9 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of TNFSF9 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TNFSF9 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing TNFSF9 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TNFSF9 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by TNFSF9 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting TNFSF9 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TNFSF9 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by TNFSF9 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of TNFSF9 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TNFSF9 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for TNFSF9 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TNFSF9 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of TNFSF9 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving TNFSF9 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving TNFSF9 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving TNFSF9 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of TNFSF9 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TNFSF9 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TNFSF9 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TNFSF9 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of TNFSF9 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TNFSF9 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TNFSF9 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of TNFSF9 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of TNFSF9 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of TNFSF9 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of TNFSF9 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TNFSF9 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TNFSF9 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TNFSF9 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TNFSF9 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TNFSF9 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TNFSF9 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving TNFSF9 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving TNFSF9 protein from the WikiPathways Pathways 2024 dataset. | |